Company intelligence / Profile preview

VIVOLABS

Alcobendas, Madrid, Spainvivolabs.es ↗

Ownership: Private
Development stage: Commercial

Overview

VIVOLABS is a Spanish leader in molecular genetics, offering a broad portfolio of genetic tests for predictive medicine, rare disease diagnosis, nutrigenetics, celiac disease screening, and pharmacogenetics. With over 20 years of experience and industry certifications, the company serves both national and international markets. It also provides specialized university training in clinical genetics through its "VIVO Campus".

Therapeutic areas: GastroenterologyMetabolic DisordersRare DiseasesOther
Modalities: Diagnostic testGenetic test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on VIVOLABS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIVOLABS.

Explore the full profile